Actavis to buy Warner Chilcott in $8.5 bln deal

Mon May 20, 2013 7:16am EDT

May 20 (Reuters) - Generic drugmaker Actavis Inc will buy specialty pharmaceuticals company Warner Chilcott Plc in a stock deal valued at about $8.5 billion.

Warner Chilcott shareholders will receive 0.160 shares of the combined company, or $20.08 per Warner Chilcott share, based on Actavis's closing share price of $125.50 on May 17.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.